Aclaris Therapeutics Inc. (ACRS) Soars 5.56% on June 08

Equities Staff  |

Aclaris Therapeutics Inc. (ACRS) had a good day on the market for Friday June 08 as shares jumped 5.56% to close at $19.37. About 399,660 shares traded hands on 3,348 trades for the day, compared with an average daily volume of 269,580 shares out of a total float of 30.91 million. After opening the trading day at $18.27, shares of Aclaris Therapeutics Inc. stayed within a range of $19.65 to $17.95.

With today's gains, Aclaris Therapeutics Inc. now has a market cap of $598.65 million. Shares of Aclaris Therapeutics Inc. have been trading within a range of $30.08 and $16.01 over the last year, and it had a 50-day SMA of $18.07 and a 200-day SMA of $22.10.

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

Aclaris Therapeutics Inc. is based out of Wayne, PA and has some 96 employees. Its CEO is Neal Walker.

For a complete fundamental analysis of Aclaris Therapeutics Inc., check out’s Stock Valuation Analysis report for ACRS.

Still paying commissions on stock trades? now offers 100% commission free stock trading and flat-fee options trading for $89.95/month! Get started today by

Aclaris Therapeutics Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Aclaris Therapeutics Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: ACRS’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Market Movers

Sponsored Financial Content